The Venture Codex Logo

The Venture Codex

Overview

Biotechnology company focused on protein engineering technologies.

Total Raised

$150 M

Rounds

3

Links

Verticals

Biotechnology
Health Care
Life Science

Investment History

  1. Equity

    Jul 2024

    $25M

  2. Series B

    Jun 2022

    $65M

  3. Series A

    Oct 2020

    $60M

Team

Nenad Tomasevic

CEO and Co-Fonder

Jennifer Richardson

Vice President, Nonclinical Development

Jeff Macfarland

Senior Vice President, Finance

Matthias Will

Chief Medical Officer